STAT+: Paul Hudson out as Sanofi CEO
Sanofi is replacing Paul Hudson as CEO, amid questions about which medicines will drive the company's growth in the future.
Sanofi is replacing Paul Hudson as CEO, amid questions about which medicines will drive the company's growth in the future.
Type 2 diabetes in Indians follows a distinct and more aggressive trajectory, marked by higher insulin resistance, early β-cell dysfunction, lower BMI thresholds, and earlier disease onset. This unique phenotype…
Kangra: The Teachers Association of Dr Rajendra Prasad Government Medical College, Tanda, in Kangra district, has voiced strong dissatisfaction over the appointment of a specialist with 12 years of professional…
New Delhi: The Ministry of Health and Family Welfare has clarified that there is currently no proposal to establish a new All India Institute of Medical Sciences (AIIMS) in Meerut,…
USA: Researchers have found in a randomized controlled trial that opportunistic genomic screening for familial hypercholesterolemia combined with telegenetic counseling did not lead to a statistically significant improvement in LDL-C…
Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.
Australia: Researchers have found in a systematic review and meta-analysis that focal laser ablation offers oncological control comparable to other focal therapies while preserving functional outcomes. However, the lack of…
A recent cross-sectional study highlights the critical factors, such as lower education levels, high waist-to-hip ratios, and non-vegetarian diets, influencing uncontrolled diabetes mellitus (UDM) among type 2 diabetes mellitus (T2D)…
Researchers have found in a new study that given its natural origin, Wheatgrass (WG) may be a promising adjunct or alternative to conventional NSAIDs for short-term management of acute dental…
The rejection is the latest instance of Vinay Prasad overruling career FDA scientists to place vaccines under harsher scrutiny.